Plain-English translation of NCT07223268 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This study is testing a new approach called CARE-D-Foot-Nav that pairs patients hospitalized with severe diabetic foot wounds with a dedicated care coordinator for 20 weeks after they leave the hospital. The coordinator provides weekly support—including help managing blood sugar, wound care advice, transportation assistance, and connecting you to medical and social resources—to help your wound heal and prevent amputation. Researchers want to see if this personalized guidance actually improves healing rates and reduces healthcare disparities, especially for communities that historically face barriers to care.
Diabetic foot wounds are a serious complication that leads to over 100,000 amputations every year in the United States. Many patients, especially in underserved communities, struggle to access the complex care needed to heal these wounds because of transportation challenges, costs, or difficulty navigating the healthcare system. This trial tests whether a dedicated care coordinator can bridge that gap and help more people avoid amputation.
You likely qualify if…
You likely don't qualify if…
If you join the study, you'll be randomly assigned to either receive standard care or the CARE-D-Foot-Nav program. If you're in the special program, you'll work with a dedicated care coordinator (a certified diabetes educator) for 20 weeks after you leave the hospital. Your coordinator will meet with you for 30 to 60 minutes at least once a week—either in person or by phone—to help coordinate your care, answer questions about your wound, teach you about managing your diabetes, and connect you with resources like transportation help or food assistance. You can also call your coordinator during working hours with concerns about your foot wound.
AI-generated summary from trial data · Jun 1, 2026 · Not medical advice
United States
Sponsor
Emory University
Collaborators
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Enrollment target
~270 participants
Started
October 2025
Primary completion
August 2030
Age range
18 Years and older
Last updated on clinicaltrials.gov in October 2025.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Marcos Schechter, MD
Emory University
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.